TCF — Theracryf Share News
0.000.00%
REG - Theracryf PLC - New Manufacturing Process Patent for Ox-1
AnnouncementREG - Theracryf PLC - Non-Binding Proposal to Acquire TheraCryf’s Assets
AnnouncementREG - Theracryf PLC - Ox-1 Programme Advances to Final Toxicology Study
AnnouncementREG - Theracryf PLC - Ox-1 Addiction Programme Update
AnnouncementREG - Theracryf PLC - Key Ox-1 milestone & notice of investor webinar
AnnouncementRCS - Theracryf PLC - Potential of Preclinical Program in Mental Fatigue
AnnouncementREG - Theracryf PLC - Half-year Financial Report
AnnouncementRCS - Theracryf PLC - Marking Addiction Awareness Week
AnnouncementREG - Theracryf PLC - Notice of Results
AnnouncementREG - Theracryf PLC - Ox-1 Programme Achieves Manufacturing Milestone
AnnouncementREG - Theracryf PLC - Director/PDMR Shareholding
AnnouncementREG - Theracryf PLC - Holding(s) in Company
AnnouncementRCS - Theracryf PLC - World Mental Health Day & Q4 Conference Schedule
AnnouncementREG - Theracryf PLC - Holding(s) in Company
AnnouncementREG - Theracryf PLC - Holding(s) in Company
AnnouncementREG - Theracryf PLC - Ox-1 Patent Grant & Development Programme Update
AnnouncementREG - Theracryf PLC - Holding(s) in Company
AnnouncementREG - Theracryf PLC - Manufacturing Scale Up of Lead Ox-1 Programme
AnnouncementREG - Theracryf PLC - Result of AGM
Announcement